Table 3.
PFS multivariate cox hazards analysis
| Variables | HR | 95%CI | P | Wald | B | SE |
|---|---|---|---|---|---|---|
| Lines | ||||||
| 1 | Ref | |||||
| 2 | 0.967 | 0.694–1.347 | 0.842 | 0.039 | −0.034 | 0.169 |
| > 2 | 1.864 | 1.282–2.712 | 0.001 | 10.612 | 0.623 | 0.191 |
| Efficacy assessment | ||||||
| PD | Ref | |||||
| SD | 0.368 | 0.267–0.508 | < 0.001 | 36.838 | −0.999 | 0.165 |
| PR | 0.380 | 0.233–0.620 | < 0.001 | 14.979 | −0.968 | 0.250 |
| Ascites | ||||||
| No | Ref | |||||
| Yes | 2.200 | 1.368–3.537 | 0.001 | 10.576 | 0.788 | 0.242 |
| Lung metastases | ||||||
| No | Ref | |||||
| Yes | 1.737 | 1.262–2.390 | 0.001 | 11.484 | 0.552 | 0.163 |
| Liver metastases | ||||||
| No | Ref | |||||
| Yes | 1.260 | 0.757–2.098 | 0.374 | 0.790 | 0.231 | 0.260 |
| Bone metastases | ||||||
| No | Ref | |||||
| Yes | 1.718 | 1.099–2.688 | 0.018 | 5.631 | 0.541 | 0.228 |
| Lymph node metastases | ||||||
| No | Ref | |||||
| Yes | 1.587 | 1.089–2.313 | 0.016 | 5.786 | 0.462 | 0.192 |
| Other metastases | ||||||
| No | Ref | |||||
| Yes | 1.493 | 1.064–2.093 | 0.020 | 5.388 | 0.400 | 0.173 |
PD Progressive disease, PR Partial response, SD Stable disease